Navigation Links
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Date:4/21/2009

s TRPP8) was identified through Dendreon's in-house discovery efforts. It is an ion channel that is triggered by cold temperatures and small-molecule agonists and belongs to the melastatin subfamily - one of seven subfamilies of TRP proteins. In normal human tissues, TRPM8 is expressed predominantly in the prostate, a gland in the male reproductive system. It is over-expressed in prostate hyperplasia and multiple types of cancer including prostate cancer, breast cancer, colon cancer and lung cancer. In recent years, it has emerged that TRP channels play a diverse and key role in cell biology and in pathology. Dendreon has synthesized small molecule agonists including D3263 that activate the TRPM8 ion channel and induce cell death.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon also is developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as BPH. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.

Except for historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties surrounding the presentation of data to the FDA and approval of product applications by the FDA and risks and uncertainties inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human t
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... HAYWARD, Calif. , May 24, 2013 Solta ... in the medical aesthetics market, today reported Dr. ... of the Company,s Board of Directors effective immediately.  Dr. Knowlton ... Medical and had served as a director since 1996. ... well as our management team, I would like to thank ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... 2011 VIVUS, Inc. (NASDAQ: VVUS ) today ... the European Congress on Obesity (ECO) in Istanbul, Turkey.  ECO ... the Study of Obesity (EASO). ECO is regularly attended by ... considered to be the most important annual scientific event on ...
... and Anne Wojcicki announced a $50-million challenge spurring existing and ... to The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... new or increased gifts to The Michael J. Fox Foundation ... The Brin Wojcicki Challenge will bolster MJFF,s ongoing efforts to ...
Cached Medicine Technology:Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 2Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 3Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 4Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 5Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure 2
(Date:5/25/2013)... Albany, New York (PRWEB) May 25, 2013 ... and substances which are used to detect and create ... available for test reading and are also known as ... of research, bioscience, diagnosis and education. , This market ... use of reagents in the field of therapeutics, growth ...
(Date:5/25/2013)... Idaho (PRWEB) May 25, 2013 A ... prevalent type of peripheral neuropathy. According to neuropathy expert ... , it is estimated that the disorder affects almost ... common complication arising from Diabetes. The high blood sugar ... Diabetes and patients suffering from it usually tend to ...
(Date:5/25/2013)... SATURDAY, May 25 (HealthDay News) -- Many viruses and ... rabies and leptospirosis -- a bacteria-borne illness than can ... lurking at dog parks, according to a veterinarian. ... water and even the air, said Dr. Susan Nelson, ... Health Center. "Many of these serious diseases can be ...
(Date:5/25/2013)... 2013 The report “Global Food ... Functions, Applications, Ingredients, Shell Materials, Packaging, & Geography: ... food encapsulation market with analysis and forecasting of ... identifies the driving and restraining factors for the ... opportunities, and challenges. The market is segmented and ...
(Date:5/25/2013)... Dallas, TX (PRWEB) May 25, 2013 ... between those who are carrying excessive weight and their ... that for many, simply losing weight can naturally relieve ... Medicine found that improvement in sleep quality was significantly ... this six month study dated November 6th, ...
Breaking Medicine News(10 mins):Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2
... aura about cosmetic surgery that often hovers around expecting ... Medical Defence Union insurance group// has revealed that discontentment ... reasons for seeking compensation claims. , ,It is ... has been coughed up by the MDU in the ...
... beneficial as it increases the concentration, abstract reasoning and ... say these results must be interpreted with caution//. ... University Baptist Medical Center in the US studied more ... drink a moderate amount of alcohol have slightly higher ...
... those of SMS Medical College here, called off their ... copy of the Supreme Court verdict directing medicos to ... to work, their protest would continue with the support ... strike would continue to protest the proposed 27 percent ...
... federal government plans to spend in this financial year ... activities//. Among doubts on whether this enormous expenditure is ... indicated that the expenditure is paying off and is ... study that is now available on line is due ...
... in Finland to show the increased risk of ... after watching many current T.V//. The Finnish researchers ... exposure to adult-targeted programs, such as current affairs ... They also showed that passive exposure to TV ...
... to be issued after today's UN meet on AIDS, activists ... the epidemic that has claimed 25 million lives so far.// ... UN Secretary General Kofi Annan asked diplomats not to negotiate ... ,The UNGA's session hoped to arrive at a plan that ...
Cached Medicine News:Health News:New Study Conducted To Evaluate The Success Of The Federal governments Funds For HIV/AIDS 2Health News:TV Viewing Might Increase The Risk Of Sleeping Difficulties In Children’ 2
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... provide a complete hematology profile, including a ... aggregation. Aggregation testing is based on performing ... platelet activation, using either collagen or ADP ... and no special sample preparation is required. ...
... A complete range of automatic systems for ... 1 mL of blood. With the introduction ... the clinical diagnostic market a truly revolutionary ... technical limitation associated with the traditional ESR ...
... range of automatic systems for performing erythrocyte ... of blood. With the introduction of the ... diagnostic market a truly revolutionary testing system ... associated with the traditional ESR techique.,By means ...
Medicine Products: